Additional information
| Active substance | Celecoxib |
|---|---|
| Chemical name | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
| Side effects | Gastrointestinal upset, cardiovascular risk, renal impairment, risk of serious skin reactions |
| Effects | Reduces inflammation, pain, and fever |
| Dosage (sports) | Not applicable as it is not used to enhance athletic performance |
| Dosage (medical) | Typically 100 mg to 200 mg daily in one or two divided doses |
| Half-life | Approximately 11 hours |
| Main action | COX-2 inhibitor |
| Substance class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Formula | C17H14F3N3O2S |
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), protect from moisture |
| Trade name | Celebrex |
| Blood pressure | Can increase blood pressure in some individuals |
| Also known as | Celebrex |
| Strength | 200mg |
| Lab Test | Not typically required for monitoring, may monitor liver enzymes if necessary |
| Hepatotoxicity | Low (rare cases of liver toxicity) |
| Water Retention | Minimal to none |
| Use in sports | Not typically used in sports for performance enhancement |
| Manufacturer | Cipla Ltd. |
| Packing | 10 caps/blister |
Reviews
There are no reviews yet.